Breaking News Instant updates and real-time market news.

DEPO

Depomed

$8.59

0.27 (3.25%)

, COLL

Collegium Pharmaceutical

$18.15

-0.67 (-3.56%)

11:38
01/08/18
01/08
11:38
01/08/18
11:38

Depomed sees closing NUCYNTA commercial agreement with Collegium in 1H18

DEPO

Depomed

$8.59

0.27 (3.25%)

COLL

Collegium Pharmaceutical

$18.15

-0.67 (-3.56%)

  • 28

    Feb

  • 01

    Mar

DEPO Depomed
$8.59

0.27 (3.25%)

12/05/17
MZHO
12/05/17
UPGRADE
MZHO
Buy
Depomed upgraded to Buy from Neutral at Mizuho
12/05/17
NEED
12/05/17
NO CHANGE
Target $28
NEED
Buy
Collegium Pharmaceutical price target raised to $28 from $25 at Needham
Needham analyst Serge Belanger raised his price target on Collegium Pharmaceutical (COLL) after its agreement with Depomed (DEPO) to license U.S. commercial rights of Nucynta and Nucynta ER. Belanger says the transaction allows the company to "leverage its commercial infrastructure given the significant overlap with Xtampza's target audience of pain specialists", estimating that it adds about $3-$5 to the company valuation. The analyst keeps his Buy rating on Collegium Pharmaceutical, noting that the deal moves up the timelines for profitability.
12/05/17
12/05/17
UPGRADE
Target $9

Buy
Depomed upgraded to Buy after opiod exit deal at Mizuho
As previously reported, Mizuho analyst Irina Koffler upgraded Depomed (DEPO) to Buy from Neutral after the company agreed to license rights to commercialize the Nucynta franchise to Collegium (COLL). With the deal, Depomed exits the opioid space and significantly lowers its operating expenses, said Koffler, who raised her price target on Depomed shares to $9 from $6.
12/05/17
12/05/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. McDonald's (MCD) upgraded to Buy from Hold at Jefferies with analyst Andy Barish saying McDonald's is well positioned in the current environment to continue to outperform. 2. Snap (SNAP) upgraded to Overweight from Equal Weight at Barclays with analyst Ross Sandler sayign with the company's pricing transition in the later stages, Snap may start hitting or exceeding consensus revenue estimates and accelerating growth in 2018. 3. Depomed (DEPO) upgraded to Buy from Neutral at Mizuhom with analyst Irina Koffler citing the company's agreement to license rights to commercialize the Nucynta franchise to Collegium (COLL). 4. United Technologies (UTX) upgraded to Overweight from Neutral at Atlantic Equities. 5. Earthstone Energy (ESTE) upgraded to Buy from Neutral at Seaport Global with analyst Mike Kelly citing the October 18 capital raise. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
COLL Collegium Pharmaceutical
$18.15

-0.67 (-3.56%)

12/05/17
JEFF
12/05/17
NO CHANGE
Target $27
JEFF
Buy
Collegium price target raised to $27 from $15 at Jefferies
Jefferies analyst David Steinberg raised his price target for Collegium Pharmaceutical (COLL) to $27 after the company in-licensed the rights to Depomed's (DEPO) Nucynta. The move "significantly broadens" Collegium's portfolio in pain management and should be immediately accretive, Steinberg tells investors in a research note. He keeps a Buy rating on the shares.
12/07/17
PIPR
12/07/17
NO CHANGE
Target $24
PIPR
Overweight
Piper survey suggests continued strong growth for Collegium's Xtampza
Piper Jaffray analyst David Amsellem says his firm's "brief survey" of 25 pain specialists who write a significant number of prescriptions for extended-release opioids indicates that a "solid majority" of physicians view Collegium Pharmaceutical's Xtampza ER as having less in the way of tampering/abuse potential compared to OxyContin. The analyst sees "high visibility" into Xtampza's continued strong volume growth for 2018 and beyond. He reiterates an Overweight rating on Collegium shares with a $24 price target.

TODAY'S FREE FLY STORIES

EPE

EP Energy

$2.48

0.17 (7.36%)

19:00
01/22/18
01/22
19:00
01/22/18
19:00
Conference/Events
EP Energy to hold a conference call »

Management discusses its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

BRSS

Global Brass and Copper

$33.30

-0.55 (-1.62%)

18:47
01/22/18
01/22
18:47
01/22/18
18:47
Hot Stocks
Global Brass and Copper reports oil spill at Somers Thin Strip plant »

Somers Thin Strip, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$227.58

7.12 (3.23%)

, DIS

Disney

$111.10

0.51 (0.46%)

18:38
01/22/18
01/22
18:38
01/22/18
18:38
Hot Stocks
Netflix doesn't see Disney-Fox deal as a direct threat »

Says Disney (DIS) and Fox…

NFLX

Netflix

$227.58

7.12 (3.23%)

DIS

Disney

$111.10

0.51 (0.46%)

FOX

21st Century Fox

$36.96

0.7 (1.93%)

FOXA

21st Century Fox

$37.31

0.66 (1.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 30

    Jan

  • 06

    Feb

  • 07

    Feb

  • 07

    Feb

T

AT&T

$37.87

0.66 (1.77%)

, TWX

Time Warner

$94.00

0.64 (0.69%)

18:37
01/22/18
01/22
18:37
01/22/18
18:37
Periodicals
Judge orders DOJ to seek consent to give data to AT&T, Time Warner, Reuters says »

Judge Richard Leon, who…

T

AT&T

$37.87

0.66 (1.77%)

TWX

Time Warner

$94.00

0.64 (0.69%)

DIS

Disney

$111.10

0.51 (0.46%)

FOX

21st Century Fox

$36.96

0.7 (1.93%)

FOXA

21st Century Fox

$37.31

0.66 (1.80%)

VIA

Viacom

$39.30

0.1 (0.26%)

VIAB

Viacom

$33.94

0.58 (1.74%)

DISCA

Discovery

$26.33

0.62 (2.41%)

SNI

Scripps Networks

$88.77

0.27 (0.31%)

CMCSA

Comcast

$42.89

0.39 (0.92%)

CMCSK

Comcast

CHTR

Charter

$370.25

4.2 (1.15%)

ATUS

Altice USA

$21.90

0.6 (2.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 24

    Jan

  • 31

    Jan

  • 02

    Feb

  • 06

    Feb

  • 07

    Feb

  • 07

    Feb

  • 08

    Feb

  • 08

    Feb

  • 12

    Feb

  • 27

    Feb

NFLX

Netflix

$227.58

7.12 (3.23%)

18:25
01/22/18
01/22
18:25
01/22/18
18:25
Hot Stocks
Netflix says it has a ways to go to hit 60M U.S. subscribers »

Says has a ways to go to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 30

    Jan

BIVV

Bioverativ

$103.79

39.68 (61.89%)

, SNY

Sanofi

$43.20

-1.4 (-3.14%)

18:15
01/22/18
01/22
18:15
01/22/18
18:15
Downgrade
Bioverativ, Sanofi rating change  »

Bioverativ downgraded to…

BIVV

Bioverativ

$103.79

39.68 (61.89%)

SNY

Sanofi

$43.20

-1.4 (-3.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 14

    Feb

  • 16

    Feb

  • 08

    Mar

  • 25

    Mar

  • 25

    Apr

  • 02

    May

ECR

Eclipse Resources

$2.33

0.05 (2.19%)

18:12
01/22/18
01/22
18:12
01/22/18
18:12
Conference/Events
Eclipse Resources to host analyst day »

Analyst Day to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$227.58

7.12 (3.23%)

18:10
01/22/18
01/22
18:10
01/22/18
18:10
Hot Stocks
Netflix says Asia market projects 'well' »

Says very pleased with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 30

    Jan

STLD

Steel Dynamics

$46.57

0.15 (0.32%)

18:06
01/22/18
01/22
18:06
01/22/18
18:06
Hot Stocks
Steel Dynamics CEO says domestic inventory levels moderated »

Steel Dynamics CEO Mark…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

STLD

Steel Dynamics

$46.57

0.15 (0.32%)

18:04
01/22/18
01/22
18:04
01/22/18
18:04
Earnings
Steel Dynamics reports Q4 EPS 54c excluding items, consensus 52c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

IMI

Intermolecular

$1.61

0.14 (9.52%)

18:02
01/22/18
01/22
18:02
01/22/18
18:02
Hot Stocks
Intermolecular and SITRI expand alliance to address Chinese market »

Intermolecular and SITRI…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

EXFO

EXFO Inc.

$4.35

-0.05 (-1.14%)

, CHL

China Mobile

$51.97

0.45 (0.87%)

18:01
01/22/18
01/22
18:01
01/22/18
18:01
Hot Stocks
EXFO partners with China Mobile to prepare network for IoT »

EXFO Inc. (EXFO)…

EXFO

EXFO Inc.

$4.35

-0.05 (-1.14%)

CHL

China Mobile

$51.97

0.45 (0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$111.12

-1.84 (-1.63%)

18:00
01/22/18
01/22
18:00
01/22/18
18:00
Hot Stocks
Celanese announces acetyl intermediates price increases »

Celanese Corporation will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jan

SFNC

Simmons First National

$59.50

0.35 (0.59%)

18:00
01/22/18
01/22
18:00
01/22/18
18:00
Earnings
Simmons First National reports Q4 core EPS 97c, consensus 88c »

Reports Q4 core net…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

WHR

Whirlpool

$166.65

-0.88 (-0.53%)

, SSNLF

Samsung

17:59
01/22/18
01/22
17:59
01/22/18
17:59
Hot Stocks
Whirlpool chairman praises Trump's move to establish tariff on washing machines »

Whirlpool (WHR) chairman…

WHR

Whirlpool

$166.65

-0.88 (-0.53%)

SSNLF

Samsung

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 30

    Jan

AMBC

Ambac Financial

$16.02

0.07 (0.44%)

17:48
01/22/18
01/22
17:48
01/22/18
17:48
Hot Stocks
Ambac Financial announces approval of plan amendment »

Ambac Financial Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STML

Stemline

$14.25

0.7 (5.17%)

17:47
01/22/18
01/22
17:47
01/22/18
17:47
Conference/Events
Stemline participates in a conference call with JPMorgan »

Investor conference call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

EFSC

Enterprise Financial

$47.70

-0.025 (-0.05%)

17:42
01/22/18
01/22
17:42
01/22/18
17:42
Earnings
Enterprise Financial reports Q4 EPS 77c, consensus 77c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

RARE

Ultragenyx

$53.39

4.23 (8.60%)

17:41
01/22/18
01/22
17:41
01/22/18
17:41
Conference/Events
Ultragenyx participates in a conference call with JPMorgan »

Investor conference call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Apr

  • 24

    Jan

FDEF

First Defiance Financial

$53.79

-0.77 (-1.41%)

17:34
01/22/18
01/22
17:34
01/22/18
17:34
Earnings
First Defiance Financial reports Q4 adjusted EPS 92c, consensus 89c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

SJR

Shaw Communications

$21.78

0.19 (0.88%)

17:29
01/22/18
01/22
17:29
01/22/18
17:29
Syndicate
Breaking Syndicate news story on Shaw Communications »

Shaw Communications files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EPIX

ESSA Pharma

$0.22

-0.0141 (-6.02%)

17:29
01/22/18
01/22
17:29
01/22/18
17:29
Syndicate
Breaking Syndicate news story on ESSA Pharma »

ESSA Pharma files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

WRLD

World Acceptance

$87.87

2.42 (2.83%)

17:22
01/22/18
01/22
17:22
01/22/18
17:22
Hot Stocks
CFPB completes investigation in World Acceptance, will not recommend action »

World Acceptance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jan

17:20
01/22/18
01/22
17:20
01/22/18
17:20
Conference/Events
CFA Society of New York to hold a discussion »

The CFA Society of New…

RBB

RBB Bancorp

$26.97

0.09 (0.33%)

17:19
01/22/18
01/22
17:19
01/22/18
17:19
Earnings
RBB Bancorp reports Q4 EPS with items 29c, consensus 39c »

Reports Q4 provision for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.